How Do the Guidelines Say Drug Testing Should Be Used?
For healthcare organizations and professionals (B2B) · Physician-led · Updated 2026-07-12 · CLIA #45D2048957 · CAP #8722734
Guidelines position drug testing as a clinical tool — and warn against using a result to punish or discharge a patient.CLIA #45D2048957 · CAP #8722734 · Same-day results · Walk-ins welcome
Consistently across sources: as a clinical instrument, individualized, and interpreted by a clinician. ASAM's appropriate-use consensus emphasizes individualized frequency and clinical interpretation. The CDC opioid prescribing guideline supports toxicology testing as part of risk mitigation while explicitly cautioning against dismissing patients from care on the basis of a result. SAMHSA frames testing as part of treatment, not surveillance.
What the guidelines converge on
| Principle | Practical consequence |
|---|---|
| Individualized frequency | Not "everyone, every visit" — that is a billing pattern, not a clinical one |
| Confirm before acting | An immunoassay result should not end a therapeutic relationship |
| Do not use results punitively | CDC cautions against dismissing patients based on a toxicology result |
| Interpret in clinical context | Prescribed medications, metabolites, timing, and the patient in front of you |
| Cover the real risk | Fentanyl must be targeted specifically — it is invisible to opiate screens |
An unexpected result is the beginning of a clinical conversation. Treating it as the end of one is how patients are pushed out of care and into the illicit supply.
Compliance. No payment for referrals, no revenue sharing, no inducements. Testing is performed on the basis of medical necessity and a physician order, at fair market value, consistent with the Anti-Kickback Statute and the Stark Law.
FAQ
- How often should patients be tested?
- Individualized and documented. Guidelines do not endorse blanket high-frequency testing.
- What if a result is unexpected?
- Confirm it definitively, then talk to the patient. Do not act on a screen.
- Do guidelines support definitive testing?
- Where it will change a clinical decision, yes.
- Where can we read them?
- Links below — CDC, ASAM and SAMHSA are all public.
References
- ASAM — Appropriate Use of Drug Testing in Clinical Addiction Medicine
- CDC — Clinical Practice Guideline for Prescribing Opioids (2022)
- SAMHSA — Substance Use Treatment Resources
- Our CLIA #45D2048957 and CAP #8722734 credentials — verify them yourself
Reach us — privately
No name needed to ask a question. Text is the fastest way to reach us.
Or send your details below — we will reply by text or email during open hours.